分化型甲状腺癌患者术后左甲状腺素最佳初始剂量预测模型探讨(5)
[18] OJOMO KA，SCHNEIDER DF，REIHER AE，et al. Using body mass index to predict optimal thyroid dosing after thyroidectomy[J]. J Am Coll Surg，2013，216(3)：454- 460.
[19] MISTRY D，ATKIN S，ATKINSON H，et al. Predicting thyroxine requirements following total thyroidectomy[J]. Clinical Endocrinology，2011，74(3)：384-387.
[20] WANG LY，SMITH AW，PALMER FL，et al. Thyrotropin suppression increases the risk of osteoporosis without decreasing recurrence in ATA low- and intermediate-risk patients with differentiated thyroid carcinoma[J]. Thyroid，2015，25(3)：300-307.
[21] SEVERI S，MALAVOLTI M，BATTISTINI N，et al. Some applications of indirect calorimetry to sports medicine[J]. Acta Diabetologica，2001，38(1)：23-26.
[22] MOREIRA DG，MARASSI MP，CORREA DA COSTA VM，et al. Effects of ageing and pharmacological hypothyroidism on pituitary-thyroid axis of dutch-miranda and wistar rats[J]. Experimental Gerontology，2005，40(4)：330- 334.
[23] ABONOWARA A，QURAISHI A，SAPP JL，et al. Prevalence of atrial fibrillation in patients taking TSH suppression therapy for management of thyroid cancer[J]. Clin Invest Med，2012，35(3)：E152-E156.
[24] 李二樂，拓明祥，田青.良性甲状腺结节切除术后口服左旋甲状腺素片效果的随访研究[J].延安大学学报(医学科学版)，2018，16(2)：35-38.
(收稿日期：2018-09-21 修回日期：2018-12-18)
(编辑：邹丽娟), 百拇医药(李林通 计成 严思敏 桑剑锋 葛卫红)
[19] MISTRY D，ATKIN S，ATKINSON H，et al. Predicting thyroxine requirements following total thyroidectomy[J]. Clinical Endocrinology，2011，74(3)：384-387.
[20] WANG LY，SMITH AW，PALMER FL，et al. Thyrotropin suppression increases the risk of osteoporosis without decreasing recurrence in ATA low- and intermediate-risk patients with differentiated thyroid carcinoma[J]. Thyroid，2015，25(3)：300-307.
[21] SEVERI S，MALAVOLTI M，BATTISTINI N，et al. Some applications of indirect calorimetry to sports medicine[J]. Acta Diabetologica，2001，38(1)：23-26.
[22] MOREIRA DG，MARASSI MP，CORREA DA COSTA VM，et al. Effects of ageing and pharmacological hypothyroidism on pituitary-thyroid axis of dutch-miranda and wistar rats[J]. Experimental Gerontology，2005，40(4)：330- 334.
[23] ABONOWARA A，QURAISHI A，SAPP JL，et al. Prevalence of atrial fibrillation in patients taking TSH suppression therapy for management of thyroid cancer[J]. Clin Invest Med，2012，35(3)：E152-E156.
[24] 李二樂，拓明祥，田青.良性甲状腺结节切除术后口服左旋甲状腺素片效果的随访研究[J].延安大学学报(医学科学版)，2018，16(2)：35-38.
(收稿日期：2018-09-21 修回日期：2018-12-18)
(编辑：邹丽娟), 百拇医药(李林通 计成 严思敏 桑剑锋 葛卫红)